Sales Growth YoY (Last 12 Months): Iovance Biotherapeutics (IOVA)

Public company logo of Iovance Corp (IOVA)

The 12-month year-over-year revenue growth rate illustrates the dynamics of Iovance Biotherapeutics (IOVA), where the 51.60 mark serves as a key metric. Growth is driven by the scaling of the clinic network to reduce costs. Stability of output is guaranteed by its own sterile manufacturing plant in Philadelphia, while a focus on innovation is maintained by outsourcing logistics and testing to external contractors.

Iovance Biotherapeutics, Inc. (IOVA) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

Iovance Biotherapeutics, Inc. (IOVA) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Iovance Biotherapeutics
Product sample of iovance.com

This indicator tracks business expansion rates by comparing total revenue over the last 12 months with the same period last year to eliminate quarterly gaps. By analyzing the trajectory of the 12-month annual revenue change, an investor assesses the commercialization of TIL therapy by Iovance Biotherapeutics (IOVA), where a sharp increase in the metric confirms the successful market launch of a unique treatment method for advanced melanoma.

Competitors of Iovance Biotherapeutics (IOVA)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IMTX - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XNCR (Xencor Corp)|Revenue Change YoY (Last 12 Months) CMPX|Sales Growth YoY (TTM) REPL (Replimune)|Revenue Dynamics YoY (Last Twelve Months) LYEL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)